NEWS
SUBSCRIBER SEARCH (Requires Login)
  NEW DRUGS
  MARKETED DRUGS
  COMPANY
  TARGETS IN ONCOLOGY
  NEWS SUMMARIES
  COMBINATION TRIALS

Latest Updates

Second Quarter 2010 Marketed Drug Updates and Additions

Brand Name

Generic Name

Other Designation

 

Gemcitabine

 

 

Oxaliplatin

 

 

Thalidomide

 

Abraxane

Nanoparticle albumin-bound (nab) paclitaxel, paclitaxel albumin bound (PAB)

ABI-007

Afinitor (cancer), Certican (immunosuppression-ROW), Zortress (immunosuppression-USA)

Everolimus

RAD001, RAD001C

Aldara

Imiquimod

 

Arzerra

Ofatumumab

HuMax-CD20, GSK1841157

Avastin

Bevacizumab

rhuMAb-VEGF, NSC-704865, R435, RG435

Celebrex (formerly known as Celebra)

Celecoxib

SC-236, SC-58635

Ceplene (formerly Maxamine and EpiLeukin)

Histamine dihydrochloride

 

Eloxatin, Eloxatine, Elplat (Japan)

Oxaliplatin (L-OHP)

1670RB, RP 54780

Endu, Endostar

 

 

Erbitux

Cetuximab

IMC-C225

Feraheme

Ferumoxytol

Code 7228

Folotyn

Pralatrexate

PDX

Gemzar

Gemcitabine

 

Iressa

Gefitinib

ZD1839, ZD-1839

Jevtana

Cabazitaxel

XRP6258, XRP 6258 (formerly RPR116258, RPR116258A, 116258)

Mylotarg

Gemtuzumab ozogamicin

CMA-676, CDP771

Nexavar

Sorafenib tosylate

BAY 43-9006

Nikidess, Aromasin

Exemestane

FCE 24304

Polyphenon E Ointment, Veregen

 

 

Provenge

Sipuleucel-T

Antigen-presenting cells 8015 (APC8015)

Revlimid (formerly Revimid), Lenalidomide-Celgene Europe

Lenalidomide

CDC501, CDC-501, CDC-5013, CC5013, CC-5013

Rituxan (USA), MabThera (Europe)

Rituximab

IDEC-C2B8, RG105

Sutent

Sunitinib malate

SU011248, SU11248, SU-11248

Tarceva

Erlotinib

CP 358774, OSI-774, R1415, RG1415, NSC 718781

Tasigna

Nilotinib

AMN107, AMN-107

Valstar, Valtaxin (Canada)

Valrubicin

AD32

Vantas

Histrelin

Formerly RL0903

Vidaza

Azacitidine (AzaC), 5-azacytidine

NSC-102816

Xeloda

Capecitabine

Ro 09-1978, RG340

Yondelis

Trabectedin

Ecteinascidin 743, ET-743, NSC 648766

  

Home   |    Freelance Opportunities   |   New Medicine   |   Site Map   |  Order/Inquiry   
SUBSCRIBER SEARCH:   NEW DRUG   |   MARKETED DRUG   |   COMPANY   |   TARGETS IN ONCOLOGY  

NEW MEDICINE, INC.
P.O. BOX 909, LAKE FOREST, CA 92609
PHONE:  1-949-830-0448     FAX:  1-949-830-0887
INFO@NEWMEDINC.COM